192 related articles for article (PubMed ID: 33067427)
1. Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway.
Gao Y; Chen DL; Zhou M; Zheng ZS; He MF; Huang S; Liao XZ; Zhang JX
Cell Death Dis; 2020 Oct; 11(10):866. PubMed ID: 33067427
[TBL] [Abstract][Full Text] [Related]
2. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
3. Cordycepin induces apoptosis in human bladder cancer T24 cells through ROS-dependent inhibition of the PI3K/Akt signaling pathway.
Kim SO; Cha HJ; Park C; Lee H; Hong SH; Jeong SJ; Park SH; Kim GY; Leem SH; Jin CY; Hwang EJ; Choi YH
Biosci Trends; 2019; 13(4):324-333. PubMed ID: 31527329
[TBL] [Abstract][Full Text] [Related]
4. The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway.
Ui T; Morishima K; Saito S; Sakuma Y; Fujii H; Hosoya Y; Ishikawa S; Aburatani H; Fukayama M; Niki T; Yasuda Y
Oncol Rep; 2014 Feb; 31(2):619-24. PubMed ID: 24317439
[TBL] [Abstract][Full Text] [Related]
5. Cordycepin Resensitizes T24R2 Cisplatin-Resistant Human Bladder Cancer Cells to Cisplatin by Inactivating Ets-1 Dependent MDR1 Transcription.
Oh SS; Lee KW; Madhi H; Jeong JW; Park S; Kim M; Lee Y; Han HT; Hwangbo C; Yoo J; Kim KD
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32131547
[TBL] [Abstract][Full Text] [Related]
6. microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer.
Wu K; Hu Y; Yan K; Qi Y; Zhang C; Zhu D; Liu D; Zhao S
J Cell Physiol; 2020 Feb; 235(2):1247-1258. PubMed ID: 31267531
[TBL] [Abstract][Full Text] [Related]
7. Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway.
Li HB; Chen JK; Su ZX; Jin QL; Deng LW; Huang G; Shen JN
Cancer Cell Int; 2021 Dec; 21(1):706. PubMed ID: 34953496
[TBL] [Abstract][Full Text] [Related]
8. Cordycepin suppresses cell proliferation and migration by targeting CLEC2 in human gastric cancer cells via Akt signaling pathway.
Wang Y; Lv Y; Liu TS; Yan WD; Chen LY; Li ZH; Piao YS; An RB; Lin ZH; Ren XS
Life Sci; 2019 Apr; 223():110-119. PubMed ID: 30878262
[TBL] [Abstract][Full Text] [Related]
9. Cordycepin-induced unfolded protein response-dependent cell death, and AKT/MAPK-mediated drug resistance in mouse testicular tumor cells.
Chang MM; Pan BS; Wang CY; Huang BM
Cancer Med; 2019 Jul; 8(8):3949-3964. PubMed ID: 31145545
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress could induce autophagy and apoptosis and enhance chemotherapy sensitivity in human esophageal cancer EC9706 cells by mediating PI3K/Akt/mTOR signaling pathway.
Zhou F; Li YH; Wang JJ; Pan J; Lu H
Tumour Biol; 2017 Jun; 39(6):1010428317705748. PubMed ID: 28631572
[TBL] [Abstract][Full Text] [Related]
11. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of Cordycepin on the proliferation of cisplatin-resistant A549 lung cancer cells.
Cho SH; Kang IC
Biochem Biophys Res Commun; 2018 Apr; 498(3):431-436. PubMed ID: 29496448
[TBL] [Abstract][Full Text] [Related]
13. [Cordycepin inhibits the proliferation and migration of human gastric cancer cells by suppressing lipid metabolism via AMPK and MAPK activation].
Zhang X; Zhou X; Gao M; Lyu Y; Wang Y; Yang C; Piao Y; Ren X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Jun; 38(6):513-521. PubMed ID: 35732609
[TBL] [Abstract][Full Text] [Related]
14. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
15. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
Su J; Zhang F; Li X; Liu Z
Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
[TBL] [Abstract][Full Text] [Related]
16. p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax.
Kim CW; Lu JN; Go SI; Jung JH; Yi SM; Jeong JH; Hah YS; Han MS; Park JW; Lee WS; Min YJ
Int J Oncol; 2013 Nov; 43(5):1495-502. PubMed ID: 23970333
[TBL] [Abstract][Full Text] [Related]
17. Cordycepin down-regulates multiple drug resistant (MDR)/HIF-1α through regulating AMPK/mTORC1 signaling in GBC-SD gallbladder cancer cells.
Wu WD; Hu ZM; Shang MJ; Zhao DJ; Zhang CW; Hong DF; Huang DS
Int J Mol Sci; 2014 Jul; 15(7):12778-90. PubMed ID: 25046749
[TBL] [Abstract][Full Text] [Related]
18. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
[TBL] [Abstract][Full Text] [Related]
19. MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway.
Sun D; Sawada A; Nakashima M; Kobayashi T; Ogawa O; Matsui Y
Urol Oncol; 2015 Mar; 33(3):111.e17-26. PubMed ID: 25499922
[TBL] [Abstract][Full Text] [Related]
20. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
Chen J; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]